NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-186-2014-1-CA-04 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 CA National Stage 2946398 Pending
NCI E-054-2013-2-MX-04 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES MX National Stage MX/a/2015/005148 Issued
NCI E-291-2012-0-US-11 M971 Chimeric Antigen Receptors US National Stage 14/437,889 10072078 Issued PDF
NCI E-014-2007-0-JP-30 SMOOTHENED POLYPEPTIDES AND METHODS OF USE JP DIV 088291/2015 Abandoned
NCI E-291-2012-0-BR-04 M971 Chimeric Antigen Receptors BR National Stage BR112015009003-6 Issued
NCI E-291-2012-0-FR-20 M971 Chimeric Antigen Receptors FR EP 13773468.7 Issued
NCI E-291-2012-0-DE-18 M971 Chimeric Antigen Receptors DE EP 13773468.7 Issued
NCI E-291-2012-0-IT-22 M971 Chimeric Antigen Receptors IT EP 13773468.7 Issued
NCI E-291-2012-0-ES-19 M971 Chimeric Antigen Receptors ES EP 13773468.7 Issued
NCI E-291-2012-0-GB-21 M971 Chimeric Antigen Receptors GB EP 13773468.7 Issued
NCI E-269-2011-0-US-07 METHODS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) US CON 14/693,511 9921211 Issued PDF
NCI E-122-2015-1-DK-01 Virus-like Particles With Efficient Epitope Display DK ORD 201570237 Pending
NCATS E-162-2015-0-US-01 KCNH2-3.1 Inhibiting Methods and Compositions US 62/150,675 Abandoned
NCI E-272-2012-0-US-03 Compositions and Methods for Enhancing Cancer Immunotherapy US National Stage 14/436,947 Abandoned
NICHD E-098-2008-0-US-04 Methods of Determining Efficacy of Therapy For Niemann-Pick C Disease And Related Disorders US CON 14/691,272 Abandoned
NCI E-054-2013-2-CA-09 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES CA National Stage 2888896 Pending
NCATS E-010-2013-0-US-06 Sensor And Device For Real Time Detection Of Plasma Metabolites US National Stage 14/436,844 10392646 Issued PDF
NCATS E-010-2013-0-JP-05 Sensor And Device For Real Time Detection Of Plasma Metabolites JP National Stage 2015-537847 Issued
NCI E-170-2010-0-US-05 Linked Purine Pterin HPPL Inhibitors Useful As Antibacterial Agents US DIV 14/689,449 9453019 Abandoned PDF
NICHD E-259-2014-1-PCT-01 MAGNETIC RESONANCE 2D RELAXOMETRY RECONSTRUCTION USING PARTIAL DATA PCT PCT COMB PCT/US2015/026533 Expired
NCI E-054-2013-2-US-08 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES US National Stage 14/436,523 Abandoned
NICHD E-151-2015-0-US-01 Methods of Treating or Preventing Demyelination using Thrombin Inhibitors and Methods of Detecting Demyelination using Neurofascin 155 US 62/148,802 Abandoned
NCI E-181-2015-0-US-01 METHODS OF IDENTIFYING THERAPEUTIC PROTEIN TARGETS AT THE SURFACE OF CELLS EXPRESSING ONCOGENIC K-RAS PROTEIN AND USES THEREOF US 62/149,456 Abandoned
NIAID E-222-2012-0-CN-04 Use Of P47 From Plasmodium Falciparum (PFS47) Or A Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission CN National Stage 201380054025.3 Abandoned
NIAID E-128-2015-0-US-01 Bank Vole Prion Protein As A Broad-spectrum Substrate For RT-QuIc-based Detection And Discrimination Of Prion Strains US 62/148,679 Abandoned
NCI E-198-2012-0-CN-07 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF CN National Stage 201380053870.9 Issued
NCI E-029-2006-1-US-09 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment US CON 14/687,530 9388211 Issued PDF
NIDCR E-289-2015-0-US-02 BIOLOGICAL SAMPLING PLATFORM AND PROCESSES FOR MAKING AND USING SAME US ORD 14/686,269 Abandoned
NHLBI E-082-2001-0-US-05 Real-Time, Interactive Volumetric Magnetic Resonance Imaging US CON 14/686,631 Abandoned
NCI E-072-2014-0-US-01 Compounds for Treating Cancer, Diabetes, and HIV US 62/146,805 Abandoned
NCI E-061-2015-0-US-01 EPIDERMAL GROWTH FACTOR RECEPTOR 1 (EGFR1)-DERIVED MULTI-PEPTIDE COMPOSITIONS AND USES THEREOF US 62/146,601 Abandoned
CC E-013-2013-0-CN-04 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND CN National Stage 201380053265.1 Issued
NIAID E-112-2015-0-US-01 RSV F IMMUNOGENS AND THEIR USE US 62/146,101 Abandoned
NCI E-021-2015-0-AU-03 Anti-CD70 Chimeric Antigen Receptors AU National Stage 2015361261 Issued
NCI E-021-2015-0-AT-16 Anti-CD70 Chimeric Antigen Receptors AT EP 15718065.4 Issued
NCI E-021-2015-0-BE-17 Anti-CD70 Chimeric Antigen Receptors BE EP 15718065.4 Issued
NCI E-021-2015-0-IE-14 Anti-CD70 Chimeric Antigen Receptors IE EP 15718065.4 Issued
NCI E-021-2015-0-IT-15 Anti-CD70 Chimeric Antigen Receptors IT EP 15718065.4 Issued
NCI E-021-2015-0-GR-20 Anti-CD70 Chimeric Antigen Receptors GR EP 15718065.4 Issued
NCI E-021-2015-0-DE-10 Anti-CD70 Chimeric Antigen Receptors DE EP 15718065.4 Issued
NCI E-021-2015-0-FR-12 Anti-CD70 Chimeric Antigen Receptors FR EP 15718065.4 Issued
NCI E-021-2015-0-CZ-19 Anti-CD70 Chimeric Antigen Receptors CZ EP 15718065.4 Issued
NCI E-021-2015-0-TR-29 Anti-CD70 Chimeric Antigen Receptors TR EP 15718065.4 Issued
NCI E-021-2015-0-CH-18 Anti-CD70 Chimeric Antigen Receptors CH EP 15718065.4 Issued
NCI E-021-2015-0-GB-13 Anti-CD70 Chimeric Antigen Receptors GB EP 15718065.4 Issued
NCI E-021-2015-0-EP-06 Anti-CD70 Chimeric Antigen Receptors EP National Stage 15718065.4 Issued
NCI E-021-2015-0-LI-21 Anti-CD70 Chimeric Antigen Receptors LI EP 15718065.4 Issued
NCI E-021-2015-0-NL-22 Anti-CD70 Chimeric Antigen Receptors NL EP 15718065.4 Issued
NCI E-021-2015-0-PL-24 Anti-CD70 Chimeric Antigen Receptors PL EP 15718065.4 Issued
NCI E-021-2015-0-PT-25 Anti-CD70 Chimeric Antigen Receptors PT EP 15718065.4 Issued